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Abstract
Background: The hospital anxiety and depression scale (HADS) is a widely used instrument for evaluating psychological
distress from anxiety and depression. HADS has not yet been validated in Ethiopia. The aim of this study was to evaluate the
reliability and validity of the Amharic (Ethiopian language) version of HADs among HIV infected patients.
Methods: The translated scale was administered to 302 HIV/AIDS patients on follow up for and taking anti-retroviral
treatment. Consistency assessment was conducted using Cronbach’s alpha, test-retest reliability using intra-class correlation
coefficients (ICC). Construct validity was examined using principal components analysis (PCA). Parallel analysis, Kaiser’s
criterion and the scree test were used for factor extraction.
Results: The internal consistency was 0.78 for the anxiety, 0.76 for depression subscales and 0.87 for the full scale of HADS.
The intra-class correlation coefficient (ICC) was 80%, 86%, and 84% for the anxiety and depression subscales, and total score
respectively. PCA revealed a one dimensional scale.
Conclusion: This preliminary validation study of the Ethiopian version of the HADs indicates that it has promising
acceptability, reliability and validity. The adopted scale has a single underlying dimension as indicated by Razavi’s model.
The HADS can be used to examine psychological distress in HIV infected patients. Findings are discussed and
recommendations made.
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Introduction
The Hospital Anxiety and Depression Scale (HADS) is a widely
used health related quality of life (HRQoL) instrument for
measuring psychological distress. It was developed in 1983 by
Zigmond and Snaith [1,2] to screen and evaluate the presence and
progression of clinically significant depression and anxiety in
patients presenting at the general medical clinic. This brief scale
has 14 items with half devoted to anxiety and half to depression.
The anxiety has questions such as ‘I still enjoy the things I used to
enjoy’ (item 2) for examining depression and; ‘I get a sort of
frightened feeling as if something awful is about to happen’ (item 3)
for examining anxiety. HADS aims to assess only the non-somatic
aspects of psychological distress and as a result it does not have
items that tap somatic symptoms of psychological distress.
Since its publication, the HADS has been translated into most
of the European and some Asian languages, but very few
published studies of adoption into the African languages exist
[3]. Three reviews [4–6] and hundreds of primary studies have
been conducted to investigate its psychometric properties. In many
of the studies HADS has shown good acceptability, reliability and
validity as indicated by good response rates ($90%), high
consistencies (Cronbach’s alpha) ranging from 0.76 to 0.93 for
the anxiety and 0.72 to 0.90 for the depression subscales, and good
diagnostic/discrimination abilities [4,5]. Factor analyses of the
HADS commonly indicate the two dimensions suggested by the
original authors and the three dimensional model of Watson et al
[4,6,7]; followed by the four dimensional model of Anderson et al
[8,9] and Razavi’s one factor model in few reports [10–12].
While it is known that psychological distresses are a recognized
problem among HIV/AIDS patients and screening for them are
important clinical goals [13], there are only very few studies that
adopted the HADS in this patient group [14,15]. The HADS has
not been adopted into the Ethiopian languages. The aim of this
study was to adopt the HADS into Amharic (the language of
Ethiopia) and test its acceptability, reliability and validity among
HIV/AIDS patients.
Methods
The questionnaire
The HADS is a questionnaire intended for the diagnosis and
evaluation of anxiety and depression in non-psychiatric pa-
tients[1,16,17]. Anxiety and depression subscales are each
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16049represented by seven items. The items are rated on a four point
Likert scale ranging from 0 to 3 giving maximum and minimum
scores of 0 and 21 respectively for each subscale. Sub-scores
on the anxiety or depression subscales ranging from 0 to 7 are
considered normal; while 8 to 10 and 11 to 21 are considered
‘cause for concern’ and ‘probable cases of anxiety or depression’
respectively.
Translation
The questionnaire was translated from English to Amharic by
the author. The translated and the English versions of the HADS
were then presented to health professionals working in the study
area. The reviewers consisted of a panel of two experienced GPs,
an internist, two nurses, a clinical psychologist, two psychiatric
nurses, and a psychiatrist working at a teaching hospital. In
addition, the scale was pretested on fifteen HIV infected patients
and five non-patients where they were encouraged to comment on
the acceptability and clarity of the items and the scale as a whole.
The input of the patient and non-patient groups was also
presented for the panel. The final translated items used for data
collection were generated through consensus on the wording,
clarity and cultural equivalence of items (refer to supporting file,
File S1, for the translated scale).
Data collection
Two nurses administered the HADs through face-to-face
interviews after they completed practical training on the
procedures of data collection and standardization of interviews.
The scale was administered to a convenience sample of 302 HIV/
AIDS consecutive patients taking antiretroviral treatment (ART)
from April to May 2010 (the sample to item ratio is 22:1 and is
considered more than adequate [18]). In addition to items of the
HADS, socio-demographic and clinical variables such as age, sex,
CD4 count, WHO clinical stages (an indicator of severity of AIDS
ranging from I, less severe; to IV, very severe AIDS stage) were
incorporated. Recent results of the last two variables were
abstracted from patient cards.
Data analysis
Descriptive statistics and ceiling and floor effects were analyzed.
Floor effects indicate ‘worst health scores,’ 21 for both dimensions
of HADS and 42 for the total score; while ceiling effects indicate
‘best health scores,’ with a score of zero for both the subscale and
total score.
Reliability was assessed using consistency and test-retest
reliability analysis. Cronbach’s alpha was used to indicate
consistency reliability, where an alpha of 0.7 to 0.9 was considered
good [19]. Test-retest reliability was examined by re-administering
HADs after two weeks on the initially interviewed half of the
sample. Test-retest reliability was assessed using intra-class
correlation coefficients (ICC), where an ICC of more than 0.6
was considered satisfactory [19].
Correlation was examined using Pearson’s correlation coeffi-
cients for ratio scale variables and Kendal’s tau for WHO clinical
stages (ordinal measure). Discriminant validity was examined by
comparing the scores of participants in different categories of
HIV/AIDS disease severity based on the WHO clinical stage and
CD4 count quartiles using the Kruskal Wallis test.
Construct validity was analysed using exploratory factor
analysis (EFA) using principal components analysis (PCA). To
find the best fit to the data, orthogonal and non-orthogonal, as
well as the non-rotated factor analysis were conducted. Factor
loadings of more than 0.40 were considered satisfactory [18].
Findings of the PCA were further validated by split-half
reliability analysis in which the findings of the factor structure
on the whole data were repeated on random halves of the
sample. In line with recommendations [20,21], factors generated
by the PCA were extracted as valid if at least two of the following
criteria were met: (1) eigenvalues were more than the randomly
generated factors from Horn’s parallel analysis; (2) pass scree
(Cattel’s) test and; (3) eigenvalues of equal or more than unity
[22,23]. SPSS 15.0 was used for reliability and validity analysis,
while Monte-Carlo PA software was employed for parallel
analysis [24]. An alpha of less than or equal to 0.05 was
considered significant.
Ethical clearance
The author declares that no competing interests exist. The
Research Ethics Committee of Haramaya University reviewed
and provided ethical approval for the study. Each participant gave
written consent. Participants who came back after two weeks for a
second interview were refunded 10 birr ($1.50, purchasing power
adjusted) to cover transportation expenses.
Results
A total of 302 patients participated in the study (100% response
rate). The mean age of the patients was 33.8 years (SD68.4).
Baseline characteristics are shown in table 1. From the 176
participants that expressed consent to come back for a second
interview after two weeks, 144 (81.8%) returned. It took about 5–
10 minutes to administer the HADS.
Table 1. Background and clinical characteristics of HIV/AIDS
on antiretroviral treatment (ART)
a.
Characteristic N
b Percent
Sex
Male 104 34.4
Female 197 62.4
Age (Mean, sd) 33.8 68.4
Marital status
Married 129 42.7
Single 67 22.2
Divorced 61 20.2
Widowed 41 13.6
Disease stage
WHO stage I 28 9.3
WHO stage II 32 10.6
WHO stage III 214 70.9
WHO stage IV 28 9.3
CD4 count (Mean, sd)
1
st Quartile 377.4 180.7
2
nd Quartile 388.1 206.7
3
rd Quartile 424.0 340.2
4
th Quartile 498.4 212.7
Over all 394.1 208.2
aN (%) unless indicated otherwise;
bN(%) is based on number of complete responses.
doi:10.1371/journal.pone.0016049.t001
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There were no ‘floor’ effects for both subscales and the total
score. However, there was modest amount of ‘ceiling’ effect on
both subscales and the full scale as shown in table 2.
Reliability
There was good consistency between items, Cronbach’s alpha
for anxiety and depression subscales and the full scale were 0.78,
0.76 and 0.87 respectively. The ICC was 77.9% (95% CI 69.3-
84.0), 86.1% (95% CI 80.7-90.0), and 84.0% (95% CI 77.6-88.4)
respectively for anxiety and depression subscales and the full scale.
Furthermore, in the first and second tests the anxiety and
depression subscales, and the total scale correlated significantly
with their corresponding counterparts well. Statistically significant
correlations of 0.64, 0.76, and 0.72 were detected (p,0.01) for the
anxiety and depression subscales and the full scale respectively.
Construct and discriminat validity
The correlation between anxiety and depression subscales was
0.75 (p,0.000), while between the subscales and full scale it was
0.92 (p,0.000) and 0.94 (p,0.000) in the respective order. All the
items correlated with the domain specific and full scores
significantly (p,0.000). However, items correlated more to the
domain to which they belonged (p,0.000). The total score versus
item correlations had values lying in between the domain specific
correlations (p,0.000) (table 3). There was poor correlation
between the subscale and full scale scores, and WHO clinical stage
(r ,0.062, p.0.05) and CD4 counts (r,0.07, p.0.05) (table 3).
Neither the subscales nor the total score discriminated well
between quartiles of the CD4 count (p.0.05) or between WHO
stages of disease (p.0.05). The different groups had an almost
similar mean score (,4.7 for subscales, ,9.1 for the total score)
except that more severe stages had a slightly higher but statistically
non-significant score.
The principal components factor analysis (PCA) revealed a one
factor model explaining 38.4% of the variation with an eigenvalue
of 5.38, where all items loaded markedly onto this factor (table 4).
The second factor explained 7.3% of the data with an eigenvalue
of 1.02. This was not extracted as it was not above the randomly
generated criterion eigenvalue from parallel analysis and did not
fulfill the scree test criterion (table 5). The non-rotated factor
produced the most explanation of the data and excellent loadings.
The split half analysis also validated the findings of the whole
sample PCA.
Discussion
The findings indicate that the Ethiopian version of the HADS is
an easy to administer instrument for measuring emotional distress.
It showed good consistency between the items and high test-retest
reliability. The HADS has one underlying factor as indicated by
Razavi et al. [10,11] and Chaturvedi [12]. This factor explained
close to 40% of the variation within the data.
Given the 100% response rate, HADS seems to be well
acceptable by HIV infected patients. The re-administration had
also good response rate of 82.0%. The fact that patients were
willing to come back for a second interview could indicate the
minimal burden, as indicated by the limited length (only 5–10
minutes), administration of the test puts on patients; and aspects
such as good face validity of the Amharic version of HADS. This is
similar to findings from other studies. The difference in accept-
ability findings of other studies with this one mainly arises from the
fact that we used interview-based administration of HADS. HADS
takes even less time to administer (2–6 minutes) when self-
administration method is used [5,17]. The observed convenience
in this study makes HADS an easy to use and time saving tool that
could be used by non-psychiatric nurses and physicians alike in line
with the aim of the developers of the scale [5,17].
In this study HADS had very good consistency and test-retest
reliability which is similar to findings in HIV/AIDS [14] and other
patient groups [4,5]. Comparison using Bjelland et al. [4] and
Hermann’s [5] review indicates that the Cronbach’s alpha in this
study is more than or equal to the highest reports of previous
studies. This indicates good consistency between the items of the
translated instrument.
HADS scores were not different across groups of participants
based on groups of patients with different WHO disease stages or
quartiles of CD4 count. Furthermore, it did not correlate well with
bothdiseasestage and CD4countina similarmanner tothefinding
by Burgess et al. [25] and Savard et al.[14]. This could be because
disease classifications are commonly somatic based, while HADS
measures non-somatic emotional distress. This is not surprising
according to a review by Hermann [5], where severity of disease as
measured by tumor size or metastases for cancer; medical
prognosis; and proximity to death were not positively related to
scores on the HADS. In fact there are even reports of very low
scores in severely ill and near death patients [5]. However, studies
report that HADS has good discriminant validity when applied on
non-somatically distinct groups with psychological distress [4,5].
An interesting finding of this study is the unifactorial model of the
Ethiopian version of HADS, similar to the reports of Razavi [10,11]
and Chaturvedi [12] where the items loaded markedly on the first
factor. However, this is dissimilar to the common findings of
bifactorial and trifactorial models of HADS [3–6]. In the literature,
there seems to be disagreement as to the correct model of HADS.
While the developers of the scale report a two factor model, other
researchers [4–6] seriouslycontest this andcome upcommonlywith
three factors [26–28], and even up to four [9] and five factors [29].
The most disparate reports in the construct validity of the
HADS are concerning the number of underlying dimensions or
factors it possesses. Three possibilities or a combination thereof
Table 2. Scores of participants at baseline assessment
{.
HADS N Mean (SD)
Median
(range)
‘Floor’ effects, % n
(worst health score)
‘Ceiling’ effects, % n
(best health score)
Anxiety 302 4.0 (3.56) 3.00 (20) 0.00 (0) 16.90 (51)
Depression 302 3.98 (4.09) 3.00 (20) 0.00 (0) 23.20 (70)
Total 302 7.98 (7.15) 6.00 (20) 0.00 (0) 8.60 (26)
{Anxiety and depression are rated from 0 to 21 indicating best to worst health scores respectively; the total score is rated from 0 to 42 indicating best to worst health
scores respectively.
doi:10.1371/journal.pone.0016049.t002
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HADS are actually either two or more than two; the second would
be that the dimensions could differ from one patient (or socio-
cultural) group to another; and the third, probably of not least
importance and of which further discussion is made below, are
methodological such as the factor extraction criterion employed
[30]. The latter one is important when it comes to reports of the
validation of HADS. Parallel analysis is considered the most
reliable criteria for factor retention and outperforms Kaiser’s and
Catell’s criteria [20,21], however, it is underutilized by authors
that validated the HADS. Hence, the fact that authors commonly
used either Kaiser’s criteria and/or the scree (Catell’s) test for
factor retention is a strong source of difference in findings. For
instance, Karimova and Martin [29] used Kaiser’s [22] criteria of
eigenvalues above 1 when they reported 4–5 factors among
pregnant women. In this manner other authors have also reported
a bi-factorial model. This may also happen because of their
expectation of a two factor model or due to their criteria of
extraction [14,31]. Another important source of difference
between studies is socio-cultural differences that exist between
populations where conceptions of anxiety, depression and
emotional expression may differ. Furthermore, while most studies
of HADS used self administration, this study used interview based
questionnaire administration which is recommended for illiterate
participants, this approach could contribute to the observed
differences between this study and others.
Anxiety and depression scores are correlated and commonly
coexist [30,32]. Due to this, researchers contend that HADS may
be measuring emotional distress or psychological disturbance in
general rather than separate entities of depression and anxiety
[5,10,12,30]. However, even when the two dimensions of anxiety
and depression are generated theoretically, it is reported that a
practical overlap between the two is to be expected [5]. The
findings of this study imply that caregivers need to focus more on
Table 3. Correlation of items with the anxiety and depression subscales and overall score of the HADS.
(Item no.) Items, subscales and full scale HADS-A
¥ HADS - D
1 HADS- T
w
(1) I feel tense or ‘wound up’ (A) 0.73 0.54 0.67
(3) I get a sort of frightened feeling as if something awful is about to happen (A) 0.65 0.42 0.57
(5) Worrying thoughts go through my mind (A) 0.62 0.47 0.58
(7) I can sit at ease and feel relaxed 0.71 0.62 0.71
(9) I get a sort of frightened feeling like ‘butterflies’ in my stomach (A) 0.60 0.42 0.54
(11) I feel restless as if I have to be on the move (A) 0.67 0.50 0.62
(13) I get sudden feelings of panic (A) 0.64 0.49 0.60
(2) I still enjoy the things I used to enjoy (D) 0.50 0.67 0.63
(4) I can laugh and see the funny side of things (D) 0.50 0.66 0.63
(6) I feel cheerful (D) 0.63 0.73 0.73
(8) I feel as if I am slowed down (D) 0.49 0.64 0.61
(10) I have lost interest in my appearance (D) 0.55 0.67 0.66
(12) I look forward with enjoyment to things (D) 0.36 0.57 0.50
(14) I can enjoy a good book or radio or a TV programme (D) 0.39 0.62 0.55
HADS – A 1
HADS – D 0.75 1
HADS – T 0.92 0.94 1
CD4 count 0.07 0.02 0.05
All correlations are significant at the 0.01 level (2-tailed) except CD4 count (p.0.05).
1HADS – D, HADS depression subscale;
¥HADS – A, HADS anxiety subscale; HADS – T,
wHADS total score; A, anxiety; D, depression.
doi:10.1371/journal.pone.0016049.t003
Table 4. Shows factor extraction decision that takes into account different criteria (n=302)
¥.
Factors Eigenvalue
Total variance
accounted for Extraction Criteria
Decision
to extract
PA Random eigenvalue (SD) Kaiser Scree test
1 5.38 38.4% 1.35 (0.04) Yes Yes Yes Yes
2 1.02 7.3% 1.27 (0.03) No Yes No No
3 0.96 6.8% 1.21 (0.03) No No No No
¥The non rotated factor analysis provided the best fit to the data; Kaiser-Meyer-Oklin (KMO) sampling adequacy equals 0.92; All anti-image matrices measures of
sampling adequacy (MSA) were greater than 0.90; Bartlett’s test of sphericity, p,0.001; Yes, indicates criteria is fulfilled, No indicates otherwise. Kaiser recommends
extracting factors with eigenvalue of $1; Scree (Cattel’s) test recommends extracting factors above the elbow of the scree plot; PA, parallel analysis.
doi:10.1371/journal.pone.0016049.t004
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anxiety and depression. For the sake of convenience, the cut off
($13 and $19 on the total score indicating levels of distress)
suggested by Razavi et al. [11] may be employed until further case
finding studies reliably estimate better cut offs based on specificity
and sensitivity analyses.
Limitations
This study has limitations. The study did not employ backward-
forward translation method. It would have been more productive
had this method been used. Despite this limitation, pre-test was
done and the reviewers debated and revised the translation and
wording of the Amharic version of the HADS rigorously before
reaching the final version. Concurrent (diagnostic) validity was not
assessed using gold standard (criterion) interviews or parallel
measurements of anxiety and depression as there are no validated
instruments for measuring anxiety or depression in Ethiopia. Had
such instruments been used, the discriminatory validity analyses
would have also been more dependable as these measurements
would provide known groups of participants with a specific
emotional distress. Due to this, the findings of discriminatory
analysis need to be interpreted with caution.
Conclusions
This preliminary validation study of the Ethiopian version of the
HADs shows that it has promising acceptability, reliability and
validity but not yet conclusive. The adopted scale has a single
underlying dimension as indicated by Razavi’s model. The HADS
can be used to examine psychological distress in HIV infected
patients. Additional studies need to be conducted to further
explore the validity, reliability and case finding ability of this brief
and easy-to-use scale not only in HIV/AIDS but also in other
patient groups.
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